Quarterly Result5 Nov 2026, 05:05 pm
Eiko Lifesciences Declares Un-Audited Financial Results
AI Summary
Eiko Lifesciences Ltd announced its un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results along with the Limited Review Report. Additionally, the company's wholly-owned subsidiary, Eiko Scientific Solutions LLP, received approval to form a 50-50 joint venture named Oval Eiko Resources Private Limited with Oval Projects Engineering Limited. This new entity will operate in the business of resources.
Key Highlights
- Board approved un-audited financial results for Q2 FY27 and H1 FY27.
- Limited Review Report from statutory auditors was also approved.
- Subsidiary to form a 50-50 joint venture with Oval Projects Engineering.
- New JV will operate under the name Oval Eiko Resources Private Limited.
Price Impact
More from EIKO